Details of the interdependent, trophic relation between smooth muscle and its neural innervation are not well known despite suggestions that neural influences may contribute significantly to hypertensive and other cardiovascular disease. Vascular smooth muscle is a major target of innervation by neurons of the sympathetic nervous system. Sympathetic neurons depend on a constant supply of the potent neurotrophic peptide nerve growth factor. Nerve growth factor regulates an impressive list of neuronal and perhaps muscle properties, yet its source in vessels and the determinants of its synthesis are not known. We have taken advantage of the cytoarchitecture of the aorta to demonstrate that vascular smooth muscle cells synthesize nerve growth factor. The survival of cultured sympathetic neurons is supported in a nerve growth factor-dependent manner by co-culture with pure rat aortic vascular smooth muscle cells. Furthermore, pure smooth muscle cell cultures contain nerve growth factorspecific messenger RNA. Levels of messenger nucleic acid coding for nerve growth factor in smooth muscle are regulated by contractile agonists (angiotensin II, arginine vasopressin) and the adrenergic agonist phenylephrine. This suggests a link between muscle activity and growth factor production. Secretion of nerve growth factor protein by vascular smooth muscle was measured using a sensitive two-site immunoassay. Secretion is highest during muscle growth. Secretion is elevated by angiotensin II and arginine vasopression but slightly inhibited by phenylephrine. These results suggest that cultured vascular smooth muscle can serve as a useful model in which to study the cellular regulation of trophic factor synthesis in health and disease. (Hypertension 1991;18:730-741)
growth-promoting effects on sympathetic neurons. Exogenous NGF induces neurite outgrowth, enhances neurotransmitter synthetic capacity, and causes a generalized neuronal hypertrophy. 4 - 6 Implicit in these results is the failure of sympathetic neurons to synthesize the necessary supply of NGF.
The presumed source of NGF for sympathetic neurons is the target tissues. This is supported by the correlation between the density of sympathetic innervation of various tissues and the levels of both NGF protein 7 and messenger RNA (mRNA) for NGF 8 -9 present in tissue homogenates. Also, in situ hybridization with NGF-mRNA-specific nucleotide probes suggests that the cell receiving neuronal input from NGF-dependent neurons is a site for NGF synthesis. 10 This dependence on NGF is not limited to development. Gorin and Johnson 5 demonstrated that adult sympathetic neurons also require a supply of NGF by generating adult animals with high titers of circulating anti-NGF. Regression of the sympathetic ganglia, neuronal death, retraction of dendrites, and loss of neurotransmitter synthetic capacity were all caused by the autoimmunity to NGF. This suggests dependency on NGF continues into adulthood, and that NGF either regulates or influences sympathetic innervation. The amount of NGF secreted by the target tissue has been suggested to directly regulate innervation. 2 Increased NGF has recently been shown to be responsible for some of the neuronal plasticity associated with bladder hypertrophy (Reference 11 and J.B. Tuttle and W.D. Steers, unpublished observations).
The vasculature is a major target of mammalian sympathetic neurons. NGF levels in the vasculature also correlate with levels of sympathetic innervation. The more densely innervated mesenteric arteries contain more NGF than the aorta. 12 This suggests that each vascular structure produces an amount of NGF appropriate to its sympathetic innervation or that the amount of NGF produced results in the observed level of innervation. Because excess NGF causes abnormal growth and anti-NGF causes recession in the adult, too much or too little NGF in a vessel would cause relative hyperinnervation or hypoinnervation. Head and coworkers 1213 have suggested a role for excess NGF in the spontaneously hypertensive rat (SHR). Vessels in the SHR become hyperinnervated and contain excess norepinephrine and nerve terminals. 1314 Vessels from young SHRs contain more NGF than controls. 12 Thus, NGF may regulate the normal innervation of the vasculature, and disturbances in this regulation may contribute to disorders. A recent report even suggests that NGF may contribute to smooth muscle hypertrophy. 15 Despite these data, there is little information available on the cellular site of NGF synthesis in vessels, or by target cells of NGF-responsive neurons in general. The critical questions of the proximate stimuli for regulation of NGF synthesis are also unanswered. We have taken advantage of the cytoarchitecture of the aorta to demonstrate that the vascular smooth muscle (VSM) cell, the innervation target of sympathetic neurons, synthesizes NGF. Furthermore, both contractile agonists and the growth status of VSM profoundly influence the amount of NGF synthesized and secreted by VSM. These results suggest that VSM is a useful model in which to examine the cellular regulation of trophic factor production in both health and disease. Some of these results have been presented previously in abstract form. 16 
Methods

Cell Cultures
Sympathetic neurons were obtained from superior cervical ganglia (SCG) of newborn rats in accord with institutionally approved protocols for animal experimentation. Pups were asphyxiated with carbon dioxide, and the ganglia were removed and transferred to cold Tyrode's saline (mM) NaCl 130, KC13, NaHCO 3 -free Tyrode's solution for 15-20 minutes at 36°C. The trypsin was removed, and the ganglia were rinsed with Eagle's minimum essential medium (MEM) (GIBCO) supplemented with 10% (vol/vol) heat-inactivated horse serum (Hyclone, Salt Lake City, Utah), and 1% lOOx MEM vitamin mix (GIBCO), and 1% 50 x MEM amino acid mix (GIBCO). The neurons were then dissociated by trituration with a fire-polished pipette. Each microwell of a 24-well plate (Linbro, McLean, Va.) received the equivalent of one quarter to one third ganglion, approximately 5,000-10,000 cells/cm 2 . 17 Before plating, the microwells were coated with collagen by adding and then aspirating a rat-tail tendon solution (acid soluble extract, dialyzed 24 hours). The collagen was dried under ammonia vapor and sterilized overnight with UV radiation.
VSM cells were cultured from the thoracic aorta of the rat. The cultures were established according to the procedures of Owens et al. 18 Male SpragueDawley rats (Hilltop Lab Animals, Inc., Scottdale, Pa.) were asphyxiated with carbon dioxide, and their thoracic aortas were excised and placed in Hanks' balanced salt solution (HBSS) (GIBCO). The isolated vessels were cleared of excess fat and connective tissue via blunt dissection, cut longitudinally, and incubated in HBSS with 1 mg/ml collagenase (type II, 158 units/mg, Cooper Biomedical, Freehold, N.J.), 0.25 mg/ml elastase (type I, 3 units/mg, Cooper), 1 mg/ml soybean trypsin inhibitors (Cooper), penicillin (100 units/ml), and streptomycin (100 tiglml) for 15-20 minutes at 36°C. Under a dissecting microscope the adventitia was removed, and the luminal surface of the aorta was scraped with forceps to remove endothelial cells. The resulting strips were then minced and incubated in a fresh enzyme solution for 1.5-2.0 hours with trituration every 30 minutes. At the end of the incubation period, the resulting solution was filtered through an 85 jitm stainless steel mesh into 20% fetal calf serum (FCS) (GIBCO) to halt the enzyme activity. The cells were centrifuged (118& 8 minutes) and were resuspended in medium 199 (GIBCO) with 10% FCS and antibiotics. Once resuspended in medium, cells for the VSM cultures were counted with a hemocytometer and seeded at a density of 5 x 10 3 to 1.0 x 10" cells/cm 2 . On the third or fourth passage the VSM was plated in MEM with 10% horse serum and 2% chick embryo extract (prepared according to Paul, 19 except that Tyrode's was used instead of HBSS). The chick embryo extract was removed a minimum of 24 hours before the neurons were added to the microwells. Endothelial cell cultures from both pulmonary and aortic bovine endothelia were obtained as primary cell lines from the Cell Culture Core of the Fundamental Studies of Vascular Smooth Muscle Program Project (Department of Physiology, University of Virginia). Aortic endothelia were cultured in medium 199 with 10% FCS, and pulmonary endothelia grew in Weymouth's medium with 10% FCS, both supplemented with 2.4 mg/1 thymidine. Cell counts were determined by direct hemocytometer counting of cell suspensions resulting from removal of all cells from the culture plates using trypsin (GIBCO) in zero Ca 2+ saline. DNA was assayed in similar cell suspensions after sonication, using a standard curve based on calf thymus DNA (Sigma) and Hoechst 33258, as published previously. 20 
Neuronal Survival
Neuronal survival was assessed after labeling the neurons with a monoclonal antibody directed against a neuron-specific /3-tubulin. 21 After 48-72 hours, cocultures were fixed with a 1:1 mix of 4% buffered formaldehyde and MEM for 30 minutes at 36°C. The wells were rinsed three times for 5 minutes with 0.1 M phosphate-buffered saline (PBS), pH 7.4. Each well received 300 /xl of the anti-tubulin antibody solution (4 /ig/ml antibody, 5 mg/ml [0.5%] bovine serum albumin [BSA], and 5 jul/ml [0.5%] Triton X-100 in 0.1 M PBS). The plate was placed in a humidified chamber at room temperature overnight. The next day the wells were washed three times for 5 minutes with PBS, and 300 fi\ peroxidase-labeled anti-mouse secondary antibody (Hyclone), diluted 1:100 in PBS with 0.5% BSA, was added to each microwell for 2 hours at room temperature. After excess secondary antibody was removed, the neurons were stained with the peroxidase substrate diaminobenzidine (3,4,3',4',-tetraaminobiphenyl, Sigma) (DAB). DAB forms an insoluble brown reaction product when oxidized. The DAB solution contained 0.04% DAB in 0.1 M PBS and 0.1 M imidazole; 30% H 2 O 2 (Sigma) was added at 0.3 Ail/ml DAB solution just before use. After staining, neurons within and along one border of a strip through the center of the microwell were counted. At X100 magnification, the area surveyed was 10.7% of the total area of each well. The results of individual experiments are reported as neurons per well. When comparing different platings, the results are presented as percents of internal controls to normalize different plating densities.
Northern Blot Hybridization
VSM cells cultured in 75-cm 2 flasks or 100-mm dishes were harvested for mRNA extraction. The cells were rinsed with zero Ca 2+ ,Mg 2+ Tyrode's and exposed to 0.1% trypsin for 2-5 minutes and then were transferred to a 50-ml centrifuge tube containing horse serum to inactivate the trypsin. After all the plates had been harvested, the cell suspension was triturated, and a sample was removed for counting with a hemocytometer. The cells were then pelleted in a clinical centrifuge at full speed for 5 minutes, frozen in liquid nitrogen, and stored at -70°C. mRNA was isolated directly using the Fasttrack mRNA Isolation Kit (Invitrogen Corp., San Diego, Calif.) according to the manufacturer's instructions. Alternatively, total RNA was isolated after guanidine isothiocyanate extraction, 22 and polyadenylated RNA was obtained after a single pass over an oligo-dT cellulose column. 23 RNA samples were denatured with formaldehyde and separated on 1.2% agarose gels containing 6.1% formaldehyde. After electrophoresis, the RNA was transferred to a Gene Screen nylon filter (New England Nuclear, Dupont, Wilmington, Del.) via capillary action overnight in 20 X sodium chloride/sodium citrate (SSC) (3 M NaCl, 0.3 M sodium citrate, pH 7.0). The blot was rinsed in 2x SSC, wrapped in plastic wrap, and fixed with UV light for 3-5 minutes (254 nm, 500 /xW/ cm 2 ). The blot was hybridized immediately or stored at -20°C overnight.
A genomic rat NGF probe, kindly provided by Dr. S.R. Whittemore, was used to generate labeled antisense RNA for hybridizations. The probe contains the BstEIl-Pst I fragment of the rat NGF gene subcloned into the vector pBluescript. 24 A Riboprobe kit (Promega, Madison, Wis.) was used to generate a phosphorus-32 cytidine triphosphate (CTP)-labeled complementary RNA (cRNA). The blots were prehybridized for 4-24 hours at 65°C in 50% deionized formamide, 2.5 x sodium chloride/sodium phosphate/ EDTA (SSPE) (0.8 M NaCl, 50 mM NaPO 4 , 1 mM EDTA), 2.5 x Denhardt's (0.05% BSA, 0.05% ficoll, 0.05% polyvinyl pyrrolidone), 5% sodium dodecyl sulfate (SDS), 250 Mg/ml herring sperm DNA (sheared and sonicated; boiled for 10 minutes), and 500 /xg/ml yeast transfer RNA (tRNA). The labeled probe was added to a fresh batch of the same solution, and the blot was hybridized in a 65°C shaking water bath for 48 hours. After hybridization, the blot was washed twice with 2x SSC containing 0.1% SDS for 10 minutes at room temperature and once with 0.2 x SSC containing 0.1% SDS for 30 minutes at 60°C. The blot was then transferred to a container with 0.2 x SSC containing 0.1% SDS and 0.1 /ig/ml RNase for 60 minutes at room temperature. After a final rinse in 2x SSC containing 0.1% SDS, the blot was wrapped in plastic wrap and exposed to X-OMAT K x-ray film (Kodak, Rochester, N.Y.) using an intensifying screen (Dupont) at -70°C.
Enzyme-Linked Immunoassay
A two-site enzyme-linked immunoassay (ELISA) for NGF was adapted from the methods of Weskamp and Otten 25 and Hellweg et al. 26 MaxiSorp 96-well plates (Nunc, Newbury Park, Calif.) were coated with 150 fi\ of 0.5 ju,g/ml anti-NGF monoclonal antibody (Boehringer Mannheim, Indianapolis, Ind.) in 50 mM sodium carbonate buffer, pH 9.6, for 2 hours at 36°C. Remaining sites on the plate were blocked with 200 fi\ of 1.0% BSA in carbonate buffer for 1 hour at 36°C. The plate was then washed one time for 1 minute and three times for 5 minutes with 250 /xl of wash buffer containing 0.4 M NaCl and 0.1% Triton X-100 in 0.1 M phosphate buffer, pH 7.4. The final wash was replaced with 100 yd of either sample or known amounts of NGF diluted in sample buffer. Four wells were used for each sample and standard curve value. The purified 2.5S mouse NGF used for the standard curve was the generous gift of Dr. E.M. Johnson. The samples were incubated overnight at room temperature in a humidified chamber. On the following day, the plate was washed one time for 1 minute and three times for 20 minutes. The plate was agitated during the washes using an insulated plate adapter on a Vortex set at one. Each well then received 10 milliunits /3-galactosidase-linked anti-NGF (Boehringer Mannheim) in wash buffer for 2 hours at 36°C. Unbound /J-galactosidase was removed during washes (one time for 1 minute and three times for 1 hour) with intermittent agitation. During the last wash, 44 mg chlorophenol red-/J-Dgalactopyranoside (CPRG) (Boehringer Mannheim) was dissolved in 22 ml of 100 mM HEPES, 150 mM NaCl, 2 mM MgCl 2 , 0.1% (wt/vol) sodium-azide, and 1% (wt/vol) BSA, pH 7.0. The plate was rinsed once with 250 til CPRG buffer, and 200 fil of the CPRG solution was added for 4-6 hours at 36°C. The plate was read on a Titretek plate reader (Flow Laboratories, McLean, Va.) using a 575 nm filter. The standard curve was calculated after subtracting the mean absorbance reading of sample buffer alone. Any value falling within 3 SDs of this zero NGF reading was considered below the limit of detection. The assay was typically sensitive to 3 pg/ml (0.3 pg/well).
Conditioned medium samples were directly applied to the ELISA plate. Conditioned medium was removed from the culture wells and placed at -20°C for up to 48 hours, or at -70°C for longer storage. Cell samples were solubilized in ELISA sample buffer (0.1 M phosphate, pH 7.0, with 0.4 M NaCl, 0.1% Triton X-100, 0.5% BSA, 0.1 mM benzethonium chloride, 2.0 mM EDTA, 20 KlU/ml aprotinin, 2.0 mM benzamidine, 0.05% sodium-azide, and 0.1 mM phenylmethylsulfonyl fluoride [added just before use]). The cells were lysed with 50 /nl/cm 2 of sample buffer, and the bottom of the dish was scraped with a rubber policeman; when 24-well plates were used, the cell samples were pooled. The NGF for the standard curve was freshly diluted in sample buffer or MEM for each assay.
Results
SCGs from the neonatal rat were dissociated and co-cultured with a confluent layer of pure VSM cells derived from the rat aorta. After 3 days, the cultures were fixed and stained with a neuron-specific antibody. Cell counts revealed that VSM cells promoted neuronal survival equivalent to 50 ng/ml exogenous NGF (Figure 1 ). In the absence of NGF, few of the neurons plated alone on either a collagen or laminin substrate survived. Since SCG neurons require NGF, survival on VSM indicated that the VSM cells were producing NGF. This was confirmed by adding anti-NGF antibody to the co-cultures. Anti-NGF essentially blocked the survival effect of the VSM ( Figure  1) ; in 10 independent experiments, 0.5-1.0 /ig/ml anti-NGF reduced survival by 52-99% (79±6%, mean±SEM). In addition to promoting neuronal survival, the VSM served as a receptive substrate for neuronal outgrowth. In the co-cultures, neurons tended to send out fewer but more extensive neurites (Figures 2A-2C) . Plated directly on a laminin substrate, the neurites encircled the neuron with multiple, fine, varicosed branches ( Figures 2D-2F ). This difference possibly reflects the diversity of the extra- cellular matrix molecules produced by the VSM cells or production of additional growth factors not blocked by the anti-NGF, or both.
The survival experiments suggest that VSM cells produce and secrete the NGF that supports the SCG neurons, a model of what may occur in vivo. However, the neuronal dissociates were not preplated and contained support cells from the ganglion. The VSM might therefore be acting indirectly. We did not determine the extent of contamination in the cocultures, raising the possibility that the NGF is produced by ganglionic nonneuronal cells. To establish independent production of NGF by VSM cells, poly(A)+ RNA was extracted from pure VSM cultures. Northern blots were labeled with antisense RNA generated from a rat NGF genomic probe. 24 The probe labeled a single band in poly(A)+ RNA from cultured VSM cells (Figure 3 ). The labeled band in the VSM lane ran parallel with the labeled band in dilutions of mouse submaxillary gland poly(A)+ RNA. The male mouse submaxillary gland contains high levels of NGF protein and relatively large amounts of NGF mRNA. The size of the band was estimated to be 1.3 kb, which is in agreement with previous work. 27 The probe did not bind to mRNA isolated from skeletal muscle, a tissue receiving minimal input from NGF-dependent neurons in vivo. Duplicate samples of the VSM and submaxillary gland poly(A)+ RNA were also hybridized with a labeled sense probe, but no specific signal was detected (data not shown).
The presence of NGF mRNA in the VSM cells confirmed their potential for NGF production. To confirm their identity as VSM cells, cultures were stained with an antibody directed against a smooth muscle-specific isoform of actin. 28 Smooth musclespecific a-actin is recognized as one marker for VSM cell differentiation in vitro. 1828 When the cultures were labeled with the antibody, all of the cells stained positive (Figure 4 ). By this marker, then, the cells in culture maintained their VSM identity. The ability to synthesize and secrete NGF was not dependent on the primary isolation from which the cells originated, nor on the passage (cells were not used beyond the 18th passage). NGF production was therefore not likely the result of an in vitro transformation. NGF synthesis in vitro appears to reflect a normal property of the VSM cell in vivo. A VSM source for NGF in intact vessels was substantiated further by the lack of NGF secretion by cultured endothelial cells. Cultures of pulmonary and aortic endothelium were grown to confluence or subconfluence in six-well multiwell plates and 1.5 ml of 24-hour conditioned medium assayed for NGF, as with the VSM (vide infra). No NGF was detected in 12 wells in two separate experiments (data not shown). To rule out NGF degradation during the 24-hour period, additional wells contained aprotinin (40 units) and leupeptin (1 mM). No effect was seen on cell viability, but the anti-proteases did not cause NGF secretion to be detected. Therefore, endothelial cells do not appear to secrete detectable levels of NGF under these culture conditions.
To study the regulation of NGF secretion, we used a two-site ELISA to measure NGF levels in condi- tioned medium and cell lysates. When confluent VSM cells were cultured in medium containing 10% horse serum for 24 hours, the conditioned medium contained up to 35 ±2 pg/ml NGF (mean±SEM, n=14 independent samples from six different assays). The absolute level of NGF depended on the volume of medium used over the cultures and the cell density in the cultures. In cell lysates of pure VSM cultures, the amount of NGF was near the level of detection (7.2±1 pg/ml, n=3). This is consistent with the suggestion that NGF is not stored and that its release is via the constitutive pathway. 2 SCG neurons plated at 6,000 cells/cm 2 reduced the amount of NGF in the medium by 64% ( Figure 5) . However, the reduction in NGF in the medium was equivalent to the increase in the cell fraction ( Figure  5 ). Although this was a single experiment, identical results were obtained using dorsal root ganglia, which also contain NGF-dependent neurons. Co-culture thus had no apparent effect on NGF synthesis, but interpreting co-culture results can be complicated because neurons continually process the NGF released into the medium. Also, we did not localize the NGF in the cell fraction to the neuronal compartment, leaving open the possibility that the increase was in the VSM and not due to neuronal uptake.
Neurons also communicate with their target via the release of neurotransmitters. Contractile agonists therefore represent another possible mode of NGF regulation. In our experiments, addition of the a-adrenergic agonist phenylephrine (10 /iM for 24 hours) did not increase the amount of NGF in the medium ( Figure 6 ). However, angiotensin II (Ang II) (1 ^M for 24 hours), a potent nonneuronal contractile ago- 
FIGURE 5. Bar graphs show nerve growth factor (NGF) content in the conditioned medium (CM) and cell lysates of vascular smooth muscle (VSM) cultures and superior cervical ganglion (SCG)-VSM co-cultures. Medium conditioned by the cultures for 24 hours was removed and assayed for NGF content using a two-site enzyme-linked immunoassay (ELISA). Cells were harvested in ELISA sample buffer and also assayed. NGF was readily detected in the medium conditioned by VSM cells, but the cells themselves contained little NGF, sometimes below the sensitivity limit of the assay for the volume harvested. In the co-cultures, however, NGF was detected in the cell fraction as well as the medium. The amount of NGF recovered in both the conditioned medium and cell lysates did not equal that in the conditioned medium of VSM alone. Neuronal processing of NGF might account for the difference. Alternatively, NGF bound to the high affinity neuronal receptors might not be detected in the ELISA. Results are from a single experiment, but identical results were obtained in two additional trials using chick dorsal root ganglion neurons.
nist, enhanced NGF output. Agonists were added in medium containing 10% horse serum, which stimulates NGF production independently. In serum-free medium (SFM), the basal rate of NGF synthesis was very low. The agonists were also added in SFM to P E A l l FIGURE 
Effect of contractile agonists on nerve growth factor (NGF) messenger RNA (mRNA) expression. Cultured cells were treated for 4 hours with either phenylephrine (PE) (10 ixM) or angiotensin II (1 fiM) in medium containing 10% horse serum. Northern blot of poly (A) + from each culture condition (C, control) was hybridized with a phosphorus-32-
FIGURE 6. Bar graph shows effect of contractile agonists on nerve growth factor (NGF) production in vascular smooth muscle (VSM) cells. Post-confluent cultures of VSM cells were treated with contractile agonists in 10% horse serum medium. After 24 hours, the medium was removed and assayed for NGF. Addition of phenylephrine (PE) (10 fiM) had little effect on NGF production, although it may have caused a slight reduction (94±2%). Angiotensin II (All) (1 yM) caused an increase in the amount of NGF detected in the conditioned medium (139±12%). Results are the mean values (±SEM) of the percent of the control from five independent experiments.
assure that the serum did not mask or inhibit any effect of the agonists. In two SFM experiments, phenylephrine again did not increase and Ang II stimulated NGF output (data not shown). The effect of the agonists was also reflected in the NGF mRNA levels after 4 hours, indicating that Ang II causes an increase in NGF mRNA (Figure 7) , whereas phenylephrine has a lesser effect. The responsiveness of VSM cells to phenylephrine and Ang II was confirmed by measuring Ca 2+ influxes with the fluorescent Ca 2+ indicator indo-1. 29 Both agonists caused increases in intracellular Ca 2+ , although the Ang II response was more pronounced (data not shown). Thus, the cells used for these studies maintained expression of the elements necessary to respond to the agonists.
The effect of cell cycling or density on NGF synthesis was determined by monitoring NGF production in cultures as they progressed from actively dividing to quiescent. Beginning 2 days after the VSM cells were plated, medium was collected at 24-hour intervals and was assayed for NGF content. The early, actively divid- ing cultures produced almost twice as much NGF as the more mature cultures despite presumably lower cell density; as the cells reached confluence, the NGF level declined (data not shown). This initial result was confirmed in a series of experiments combining cell counts and assay of total DNA in VSM cultures in parallel with assay of NGF secreted into the medium. VSM cell division was inhibited at low cell density by removal of serum from the medium. Growth was inhibited at high cell density by allowing the cultures to grow in serumcontaining medium until reaching confluency and density inhibition (Figure 8 ). To ensure that the changes in NGF secreted were not a reflection of changes in protease activity, aprotinin (40 units) and leupeptin (1 mM) were tested for effect on NGF levels. The protease inhibitors had no effect, even after 48 hours (data not shown), suggesting the NGF was recovered in proportion to secretion. In both culture conditions, with growth arrested at high or low density, NGF secretion into the medium declined as the rate of cellular growth tapered off. The components of this decline can be seen more clearly by normalizing NGF secretion to cell number or total cellular DNA ( Figure  9 ). NGF secreted per cell in serum-containing medium declines throughout the experiment from a high at subculture to a low basal rate at 15 days. In SFM, the drop is more precipitous, suggesting a stimulatory effect of serum. NGF per microgram DNA, in serum-containing medium, rises to a peak at 5 days in vitro and then declines; under serum-free conditions, the peak is not evident. These data suggest a complex relation between an effect of serum on NGF expression and a relation between NGF production and cellular growth status. Growth arrest by serum removal causes a more rapid and potent inhibition of NGF secretion than density- mediated growth suppression in the presence of serum. However, the final, basal level of secretion is low and at a similar level regardless of the path taken to that end.
Discussion
The results of this study establish VSM as a source of NGF for the sympathetic and sensory neurons innervating the muscle. In vivo sympathetic neurons depend on their target for a continuous supply of NGF. Disruption of this relation demonstrates its critical role. Daily injections of NGF to newborn mice leads to a dramatic increase in both the size and number of neurons in paravertebral sympathetic ganglia. 4 Exogenous NGF also increases the density of sympathetic fibers in the periphery and the catecholamine content in sympathetic targets. 4 -6 In contrast, depriving developing sympathetic neurons of NGF via antibodies to the NGF molecule 4 -5 or the NGF receptor 30 results in a near complete destruction of the sympathetic nervous system and significant reduction in the catecholamine content in peripheral tissues. This relation also continues in the adult animal. Chronically autoimmune rats show a 35% reduction in cells in the SCG and a 90% reduction in norepinephrine content in heart and brown fat 5 ; more extensive cell loss occurs in animals and species in which a higher titer of antibody develops. Adult sympathetic neurons continue to respond positively to NGF as well. Intracerebral NGF infusion induces sprouting of the sympathetic perivascular axons and results in hyperinnervation of cerebral vessels. 31 Changes in NGF levels can thus profoundly impact the delicate balance between sympathetic neurons and their targets.
There is still controversy over the site of NGF synthesis in vivo. Target cells have always been the presumed source, 2 but the scarcity of NGF protein and its mRNA have made positive identification difficult. This question is particularly germane to blood vessels whose density of innervation varies throughout the vasculature. Assuming that the same cell type is responsible for NGF production in every blood vessel, possibilities that might account for the differences in innervation density include 1) NGF production is intrinsically controlled or governed by the history of the cell within the tissue; 2) extrinsic signals control NGF production and are locally regulated; 3) the cells at different levels in the vasculature respond differentially to extrinsic signals (perhaps in part due to possibility 1); or 4) some combination of possibilities 1, 2, and 3. Solely intrinsic control of NGF is unlikely given the growing number of reports, including this one, documenting changes of NGF synthesis in a variety of cell types in response to a variety of stimuli. Even if basal NGF synthesis is intrinsically controlled, extrinsic factors can affect NGF output both in vitro and in vivo (see below). Thus, before considering any of these possibilities we need a better understanding of how NGF synthesis might be regulated in the target tissue.
We have demonstrated the ability of cultured VSM cells to secrete NGF and support the survival of dissociated sympathetic neurons. Demonstration of NGF synthesis in vitro does not verify that the VSM cell synthesizes NGF in vivo. However, evidence from other NGF-producing targets suggests that the VSM cell is a likely source. In situ hybridization studies of the rat and mouse brain revealed NGF mRNA in the dentate gyrus and pyramidal cell layer of the hippocampus. 32 These neurons receive projections from the NGF-responsive cholinergic neurons in the medial septal nucleus. Further support for target cell production of NGF comes from two peripheral targets: the mouse whisker pad and the rat iris.
10
- 33 In situ hybridizations failed to identify individual cells containing NGF mRNA, but labeling was heaviest in regions with axonal terminals. Thus, the cells in proximity to the neuronal terminals appear responsible for NGF production. For sensory neurons, this would include specialized sensory structure or the overlying epithelium; for sympathetic neurons this would likely be the synaptic target cell.
Several different isolated cell types or cell lines have already been used to identify potential regulators of NGF synthesis. NGF or its mRNA has been detected in cultures of L-929 fibroblasts, 34 L-M fibroblasts, 35 primary fibroblasts, 36 -38 astrocytoma cells, 39 and astrocytes. 4041 In addition to these relatively pure cell populations, the four identified cell types from the dissociated iris contain NGF mRNA. 10 -42 Organ culture of the intact rat iris first indicated that innervation might control NGF production. 43 When this tissue is placed in culture, the amount of NGF protein detectable in the tissue homogenates increases as much as 10-fold. 44 After only 12 hours in vitro, cells throughout the iris label for NGF mRNA although the most intense signal remains in the in vivo position at the posterior border of the dilator muscle, 10 and the relative amount of message in different segments of the iris remains constant. 45 In vivo denervation produces a similar increase in NGF protein, 43 -44 but this procedure does not cause a corresponding increase in NGF mRNA. 45 The observed increase in NGF protein might therefore be due to accumulation of NGF in the target after the loss of the neuronal high affinity uptake and transport system. In our in vitro experiments, the presence of SCG or dorsal root ganglion neurons had no apparent effect on NGF production. The total amount of NGF in the cultures did not significantly change, only its location. The rise of NGF in the lysate fraction and decline in the medium could be due to an increased level in the VSM, suggesting neurons alter secretion, or to the accumulation of NGF in neurons with no change in VSM NGF. Recent findings suggest developmental expression of NGF in target tissues is independent of innervation. Surgical removal of the sensory neurons innervating the skin does not prevent the expression of NGF mRNA in the chick hind limb. 46 Similarly, sympathectomy via 6-OH dopamine treatment does not alter the time course or amount of NGF mRNA in the ventricles of neonatal rats. 47 At least during development, cells within the target must therefore be responding to intrinsic cues or other factors within their environment.
The close association between a nerve and its target has prompted several investigators to study the role of neurotransmitters on NGF production. We also tested this possibility with the a-adrenergic agonist phenylephrine. At a concentration of 10 fiM, phenylephrine had little or no effect on NGF secretion in VSM cells, with only a slight but consistent reduction. In contrast to our results, Hellweg and coworkers 42 have reported catecholamine inhibition of NGF release in explanted or dissociated iris cultures. Furthermore, norepinephrine reduced the in situ hybridization signal over all of the cells with the greatest reduction occurring over smooth muscle cells. 42 It is possible that our single dose was insufficient to elicit a similar response. The observed difference is more likely due to activation of different receptor systems. In the iris cultures, the cell response did not seem to be mediated by either a or /3 receptors. 42 A similar nonadrenergic receptor mediates the effects of epinephrine and norepinephrine in astroglia and the L-M fibroblast cell line. 35 ' 48 In these cells, however, catecholamines cause an increase in NGF and NGF mRNA. The effect is apparently due to the catechol part of the molecule. All of the catecholamines demonstrated the effect but other sympathomimetic amines, including phenylephrine, did not. 35 - 48 In neurons that produce NGF, the situation may be quite different. Brain levels of NGF mRNA are dramatically elevated after activation with kainic acid. 49 It is difficult at this time to draw any general conclusions about the potential of neurotransmitters regulating NGF synthesis. 50 The increase is strictly in size and not in number. Arginine vasopressin, another potent vasoactive agent, also induces cell hypertrophy without hyperplasia, 51 and it also raises the levels of NGF secretion in VSM (R. Etheridge and J.B. Tuttle, unpublished observation). The contractile agonists, which themselves induce work, might also initiate the growth that allows the cell to accommodate the increased load. In this context, the upregulation of NGF could help maintain adequate innervation of the growing cell or tissue by promoting neurite outgrowth from nearby axons. Ang II activates the protooncogenes c-jun, c-fos, and c-myc. 52 It is tempting to suggest that these protooncogene products raise NGF mRNA levels in VSM in a fashion similar to induction of the NGF gene in glia. 53 The VSM cells also showed enhanced NGF production during log phase growth. The medium recovered from actively dividing VSM cells contained approximately four times the concentration of NGF as medium from the same cells when postconfluent. Dividing astrocytes display a similar but more substantial growth response. 40 FCS causes an increase in the amount of NGF secreted into the medium of confluent astrocytes cultures. 41 Thus, removing serum also removes a supply of unidentified regulatory factors. The results from the astrocyte cultures 40 and our own experiments indicate a role for cell cycling in the regulation of NGF. The reduction occurred in both cases even though serum was continually present in the medium. This mechanism could act in the mature animal during regular tissue growth or after injury. Regulatory mechanisms acting during development could establish the basal level of NGF synthesis for a particular cell type. As the cells within the tissue grow in response to increased functional demands, their NGF output could signal the neurons to keep pace. In this scheme the increase in NGF does not require special induction and could be part of the general response leading to cell hypertrophy or hyperplasia. In injured tissue one mechanism for inducing NGF has already been identified, but cell division could augment this response. In the rat sciatic nerve, a cut or a crush injury stimulates the production of NGF by Schwann cells adjacent and distal to the injured site. 54 Interleukin-1 from activated macrophages that invade the site are thought to mediate this increase. 55 - 56 As the inflammation subsides, cell growth and cell division could maintain high levels of NGF to help sustain the neurons during the reinnervation process.
VSM cell hypertrophy and hyperplasia are prominent features of vascular disease. Increases in NGF secretion in response to hypertrophy often seen in hypertension or the hyperplasia accompanying atherosclerosis could induce neuritic sprouting, which might further exacerbate these conditions. Conversely, an increase in the amount of available NGF could initiate or promote such pathology. There is evidence that an increase in NGF might contribute to the development of hypertension in the SHR. In addition to changes in vessel structure, 14 -5758 SHRs differ in the innervation of their vasculature, with an increased number of axon bundles. 1314 The hyperinnervation has trophic effects on the vasculature. Neonatal sympathectomy prevents morphological changes in the muscular arteries and resistance vessels, suggesting that the hyperinnervation causes the hyperplasia in these vessels. 57 - 59 Also, exogenous NGF administered to normotensive rats has an effect on the vasculature in addition to causing neuronal hypertrophy. 15 Until the precise timing of all the relevant events is determined it is difficult to assign cause and effect. However, the reciprocal trophic relation shared by neurons and VSM cells implies that a slight imbalance by either element could be positively reinforced.
This relation is not restricted to VSM but may be common to all smooth muscles. 60 Bladder smooth muscle undergoes extensive hypertrophy in response to the increased work load and stretch that accompanies outlet obstruction. 61 Bladder weight may increase by sevenfold to 10-fold. The innervating neuronal populations, both NGF-dependent and others, respond with increases in size and altered reflex function. 62 NGF levels in the bladder rise dramatically with obstruction, in experimental animals and in humans (Reference 11 and unpublished observations from our laboratory). Autoimmunity to NGF partially prevents the neuronal hypertrophy accompanying experimental obstruction, suggesting NGF participates in the plasticity of the bladder innervation.
An increase in NGF during development, after nerve injury, and in the adult can thus have significant bearing on the proper functioning of the sympathetic nervous system and its target organs. An insufficient or excess amount of NGF could prove pathological at these or any other times. Thus, the cellular control of NGF synthesis remains one of the critical unanswered questions regarding the physiology of NGF. Here we have demonstrated that cultured VSM cells are capable of producing NGF and that Ang II and cell cycling increase NGF output. We believe this system could provide not only the tools needed to investigate the control of NGF production by a sympathetically innervated target cell but also insights into the role NGF may play in vascular and other disease.
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